MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kufe, D. W.
Right arrow Articles by Fram, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kufe, D. W.
Right arrow Articles by Fram, R. J.

Lethal effects of 1-beta-D-arabinofuranosylcytosine incorporation into deoxyribonucleic acid during ultraviolet repair

DW Kufe, R Weichselbaum, EM Egan, W Dahlberg and RJ Fram

We have previously demonstrated that 1-beta-D-arabinofuranosylcytosine (ara-C) incorporates into leukemic cell DNA and that the extent of this incorporation correlates significantly with loss of clonogenic survival. These studies have now been extended by monitoring the incorporation of ara-C in DNA undergoing repair of UV-induced damage. The present studies have been performed using human foreskin diploid fibroblasts that undergo density-dependent growth arrest. The results demonstrate that ara-C incorporates specifically into DNA undergoing repair of damage by UV light. The extent of ara-C incorporation in AG1522 DNA during UV repair correlates significantly (p less than 0.0006) with cell lethality. These findings confirm that incorporation of ara-C into DNA undergoing either semiconservative or unscheduled DNA synthesis results in lethal cellular events. The present findings may provide the experimental basis for the development of new therapeutic approaches using ara-C in combination with agents that damage DNA.

Volume 25, Issue 2, pp. 322-326, 03/01/1984
Copyright © 1984 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
 Clin. Cancer Res.Home page
V. A. Rao and W. Plunkett
Activation of a p53-mediated Apoptotic Pathway in Quiescent Lymphocytes after the Inhibition of DNA Repair by Fludarabine
Clin. Cancer Res., August 1, 2003; 9(8): 3204 - 3212.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
L.-Y. Yang, L. Li, H. Jiang, Y. Shen, and W. Plunkett
Expression of ERCC1 Antisense RNA Abrogates Gemcitabine-mediated Cytotoxic Synergism with Cisplatin in Human Colon Tumor Cells Defective in Mismatch Repair but Proficient in Nucleotide Excision Repair
Clin. Cancer Res., March 1, 2000; 6(3): 773 - 781.
[Abstract] [Full Text]

Home page
 BloodHome page
H. Iwasaki, P. Huang, M. J. Keating, and W. Plunkett
Differential Incorporation of Ara-C, Gemcitabine, and Fludarabine Into Replicating and Repairing DNA in Proliferating Human Leukemia Cells
Blood, July 1, 1997; 90(1): 270 - 278.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1984 by the American Society for Pharmacology and Experimental Therapeutics